Alpha Peps
10 mg vial
- Vendor score
- 82/100
- Effective vial price
- $35
- Effective price per mg
- $3.50
GHRP-2 is commonly sold or discussed for growth hormone signaling, recovery, body composition, and performance research.
Also known as ghrp-2 · ghrp2
Historical market context
Historical market low and median per mg across recorded offers. These market summaries are separate from our exact-product comparisons.
History updated Sep 21, 2026. Vendor coverage, package sizes, product forms and promotions can vary over time. Use exact-product comparisons for current listed prices; historical market prices do not establish vendor trust.
| Date | Low /mg | Median /mg | Vendors | Offers |
|---|---|---|---|---|
| $0.54 | $3.70 | 16 | 22 | |
| $0.54 | $3.70 | 16 | 22 | |
| $0.60 | $3.70 | 16 | 22 | |
| $0.60 | $3.90 | 16 | 22 | |
| $0.60 | $3.90 | 16 | 22 | |
| $0.60 | $3.90 | 16 | 22 | |
| $0.60 | $3.90 | 16 | 22 | |
| $0.60 | $3.70 | 15 | 20 | |
| $0.60 | $3.70 | 15 | 20 | |
| $0.60 | $3.70 | 15 | 20 | |
| $0.60 | $3.70 | 15 | 20 | |
| $0.60 | $3.70 | 15 | 20 | |
| $0.60 | $3.70 | 15 | 20 | |
| $0.60 | $3.70 | 15 | 20 | |
| $0.60 | $3.70 | 15 | 20 | |
| $0.60 | $3.70 | 15 | 20 | |
| $0.60 | $3.70 | 15 | 20 | |
| $0.60 | $3.70 | 15 | 20 | |
| $0.60 | $3.70 | 15 | 20 | |
| $0.60 | $3.59 | 14 | 19 | |
| $0.60 | $3.59 | 14 | 19 | |
| $0.60 | $3.59 | 14 | 19 | |
| $0.60 | $3.59 | 14 | 19 | |
| $0.60 | $3.59 | 14 | 19 | |
| $0.60 | $3.59 | 14 | 19 | |
| $0.60 | $3.59 | 14 | 19 | |
| $2.16 | $3.70 | 13 | 18 | |
| $2.16 | $3.70 | 13 | 18 | |
| $2.16 | $3.70 | 13 | 18 | |
| $2.16 | $3.70 | 13 | 18 | |
| $2.16 | $3.70 | 13 | 18 | |
| $2.16 | $3.70 | 13 | 18 | |
| $2.16 | $3.70 | 13 | 18 | |
| $2.16 | $3.70 | 13 | 18 | |
| $2.16 | $3.59 | 13 | 17 | |
| $2.16 | $3.59 | 13 | 17 | |
| $2.16 | $3.59 | 13 | 17 | |
| $2.16 | $3.59 | 13 | 17 | |
| $2.16 | $3.59 | 13 | 17 | |
| $2.16 | $3.59 | 13 | 17 | |
| $2.16 | $3.59 | 13 | 17 | |
| $2.16 | $3.59 | 13 | 17 | |
| $2.16 | $3.59 | 13 | 17 | |
| $2.16 | $3.59 | 13 | 17 | |
| $2.16 | $3.70 | 12 | 16 | |
| $2.16 | $3.59 | 11 | 15 | |
| $2.16 | $3.45 | 10 | 14 | |
| $2.16 | $3.59 | 9 | 13 | |
| $2.16 | $3.59 | 9 | 13 | |
| $2.16 | $3.31 | 7 | 11 | |
| $2.16 | $3.00 | 6 | 9 | |
| $2.16 | $3.00 | 6 | 9 | |
| $2.16 | $3.00 | 6 | 9 | |
| $2.16 | $3.00 | 6 | 9 | |
| $2.16 | $3.00 | 6 | 9 | |
| $2.16 | $3.00 | 6 | 9 | |
| $2.16 | $3.00 | 6 | 9 | |
| $2.16 | $3.00 | 6 | 9 | |
| $2.16 | $3.16 | 5 | 8 | |
| $2.16 | $3.16 | 5 | 8 | |
| $2.16 | $3.16 | 5 | 8 | |
| $2.16 | $3.16 | 5 | 8 | |
| $2.16 | $3.16 | 5 | 8 | |
| $2.16 | $3.16 | 5 | 8 | |
| $2.16 | $3.16 | 5 | 8 | |
| $2.16 | $3.31 | 6 | 9 | |
| $2.16 | $3.31 | 6 | 9 | |
| $2.16 | $3.93 | 6 | 8 | |
| $2.16 | $3.93 | 6 | 8 | |
| $0.99 | $3.84 | 6 | 8 | |
| $0.99 | $3.84 | 6 | 8 | |
| $1.80 | $3.73 | 6 | 8 | |
| $1.80 | $3.73 | 6 | 8 | |
| $1.80 | $3.73 | 6 | 8 | |
| $1.80 | $3.73 | 6 | 8 | |
| $1.80 | $3.73 | 6 | 8 | |
| $1.80 | $3.73 | 6 | 8 | |
| $1.80 | $3.73 | 6 | 8 | |
| $2.40 | $4.50 | 5 | 7 | |
| $2.40 | $4.50 | 5 | 7 | |
| $2.40 | $4.50 | 5 | 7 | |
| $2.40 | $4.50 | 5 | 7 | |
| $2.40 | $4.50 | 5 | 7 | |
| $2.40 | $4.50 | 5 | 7 | |
| $2.40 | $4.50 | 5 | 7 | |
| $2.40 | $4.50 | 5 | 7 | |
| $2.40 | $4.50 | 5 | 7 | |
| $2.40 | $5.15 | 4 | 6 | |
| $2.40 | $5.15 | 4 | 6 | |
| $2.40 | $5.15 | 4 | 6 | |
| $2.40 | $5.15 | 4 | 6 | |
| $2.40 | $5.15 | 4 | 6 | |
| $2.40 | $5.15 | 4 | 6 | |
| $2.40 | $5.15 | 4 | 6 | |
| $2.40 | $5.15 | 4 | 6 | |
| $2.40 | $5.15 | 4 | 6 | |
| $5.80 | $6.90 | 3 | 3 | |
| $5.80 | $6.90 | 3 | 3 | |
| $5.80 | $6.90 | 3 | 3 | |
| $5.80 | $5.80 | 1 | 1 | |
| $5.80 | $5.80 | 1 | 1 | |
| $5.80 | $5.80 | 1 | 1 | |
| $5.80 | $5.80 | 1 | 1 | |
| $5.80 | $5.80 | 1 | 1 | |
| $4.40 | $5.10 | 2 | 2 | |
| $4.40 | $5.10 | 2 | 2 |
Research shortlist · Sep 12, 2026
These research selections use the same basis: 10 mg vial. The selections remain from Sep 12, 2026; each price below comes from its dated market observation.
10 mg vial
10 mg vial
10 mg vial
What it is
Pralmorelin is an oligopeptide. The listed molecular formula is C45H55N9O6. PepGrades separately preserves the catalog category because a chemical identity record does not establish a use, outcome, or product quality.
This label describes the available research record, not whether the compound is safe or effective for an individual.
Research context
No registered human trial was identified under this exact name in the current review. Published work may be preclinical or indexed under another name.
Search indexed research for this compound ↗Market context
GHRP-2 is commonly sold or discussed for growth hormone signaling, recovery, body composition, and performance research. That describes market demand, not proof that the compound is safe or effective.
Market demand and online discussion do not establish product quality, safety, or effectiveness.Same format. Same amount.
2 of 2 formats had a qualifying research shortlist on Sep 12, 2026. Vendor counts below reflect the available price observations.
Vendor directory
Grades describe the vendor record overall. They are not a test result for every product.
| Vendor | Grade | Compared offers | In stock when checked | Lowest effective package | Profile |
|---|---|---|---|---|---|
| Alpha PepsVendor grade | Grade B+ | 1 | 1 | $3510 mg vial · compare →Observed Sep 21, 2026 | View → |
| Oasis PeptidesVendor grade | Grade B+ | 1 | 1 | $39.95Automatic quantity percent off · listed $4710 mg vial · compare →Observed Sep 21, 2026 | View → |
| Core PeptidesVendor grade | Grade B+ | Not available | Not available | Not availableNo market observation | View → |
| SaiyanMedVendor grade | Grade B+ | Not available | Not available | Not availableNo market observation | View → |
| Simple PeptideVendor grade | Grade B | Not available | Not available | Not availableNo market observation | View → |
| Ion PeptidesVendor grade | Grade B | Not available | Not available | Not availableNo market observation | View → |
| RUOVendor grade | Grade B | Not available | Not available | Not availableNo market observation | View → |
| NuLife PeptidesVendor grade | Grade B | Not available | Not available | Not availableNo market observation | View → |
| Premier Bio LabsVendor grade | Grade A- | 1 | 1 | $25.65Automatic quantity percent off · listed $4510 mg vial · compare →Observed Sep 21, 2026 | View → |
| Nationwide PeptidesVendor grade | Grade B+ | Not available | Not available | Not availableNo market observation | View → |
| Vital Core ResearchVendor grade | Grade B | Not available | Not available | Not availableNo market observation | View → |
| PeptidologyVendor grade | Grade C | Not available | Not available | Not availableNo market observation | View → |
| Oath ResearchVendor grade | Grade C | Not available | Not available | Not availableNo market observation | View → |
| Swiss ChemsVendor grade | Grade C | Not available | Not available | Not availableNo market observation | View → |
| AIO PeptidesNot enough information to grade | Not enough information to grade | 1 | 1 | $24.32Automatic percent off · listed $30.405 mg vial · compare →Observed Sep 21, 2026 | View → |
| American Peptide ResearchNot enough information to grade | Not enough information to grade | Not available | Not available | Not availableNo market observation | View → |
| Atomik LabzNot enough information to grade | Not enough information to grade | Not available | Not available | Not availableNo market observation | View → |
| Nuscience PeptidesNot enough information to grade | Not enough information to grade | Not available | Not available | Not availableNo market observation | View → |
| Peptides 4 ResearchNot enough information to grade | Not enough information to grade | Not available | Not available | Not availableNo market observation | View → |
| Pharma Grade PeptidesNot enough information to grade | Not enough information to grade | Not available | Not available | Not availableNo market observation | View → |
| TydesNot enough information to grade | Not enough information to grade | Not available | Not available | Not availableNo market observation | View → |
Sources and review
Last editorial review: Aug 30, 2026. Sources support the compound guide only and do not affect vendor grades.